Judge denies motion to freeze meningitis pharmacy owners’ assets

Your Health Matters

A sign for pharmaceutical compounding company NECC, a producer of the steroid methylprednisolone acetate, is seen in Framingham, MassachusettsBOSTON (Reuters) – A federal judge on Wednesday denied a motion to freeze the assets of the owners of the compounding pharmacy at the heart of the deadly U.S. meningitis outbreak, but said the company may not make extraordinary cash transfers or pay dividends or bonuses to the pharmacy's owners. Judge Dennis Saylor, of U.S. District Court in Boston, ordered an attachment of $5 million for each of the two plaintiffs who had moved for a preliminary injunction and prejudgment attachment restraining the assets of the Framingham, Massachusetts-based New England Compounding Center. …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave